The metabolic mechanism of hepatic glucose overproduction was investigated in 3,3'-5-triiodo-L-thyronine(T 3 )-treated rats and Zucker diabetic fatty (ZDF) rats (fa/fa) after a 24 hr fast.
min under ketamine/xylazine anesthesia. 13 C NMR analysis of monoacetone glucose derived from plasma glucose indicated that hepatic glucose production was 2-fold higher in both T 3 -treated rats and ZDF rats compared to controls yet the sources of glucose overproduction differed significantly in the two models by 2 H NMR analysis. In T 3 -treated rats, the hepatic glycogen content and hence the contribution of glycogenolysis to glucose production was essentially zero; in this case, excess glucose production was due to a dramatic increase in gluconeogenesis from TCA cycle intermediates. 13 C NMR analysis also revealed increased PEPCK flux (4×), increased pyruvate cycling flux (4×), and increased TCA flux (5×)
in T 3 -treated animals. ZDF rats had substantial glycogen stores after a 24 hr fast and consequently nearly 50% of plasma glucose originated from glycogenolysis; other fluxes related to the TCA cycle were not different from controls. The differing mechanisms of excess glucose production in these models were easily distinguished by integrated 2 H and 13 C NMR analysis of plasma glucose.
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Although the pathways contributing to glucose production are well established, less is known about the effects of disease on hepatic glucose output in humans. Earlier studies examined selected aspects of glucose production in the Zucker diabetic fatty (ZDF) rat (fa/fa) and the 3,3'-5-triiodo-Lthyronine (T 3 )-treated rat. Studies in T 3 -treated animals focused on gluconeogenesis from the TCA cycle, particularly flux through phosphoenol pyruvate carboxykinase (PEPCK) and cycling pathways associated with phosphoenol pyruvate (PEP). PEP can undergo dephosphorylation to pyruvate by pyruvate kinase (PK) rather than conversion to glucose, an apparent energy-wasting process. Rognstad (26) and Cohen et al. (5) found that flux through PK was significantly higher in hepatocytes isolated from T 3 -treated rats.
Later, Petersen et al. showed that direct conversion of malate to pyruvate via the malic enzyme (ME) also contributes to this futile cycle and cannot be distinguished from the OAA → PEP → pyruvate → OAA cycle using isotope methods (22) . Flux through these combined pathways, referred to as pyruvate recycling (7) or simply pyruvate cycling (17) , is increased in livers of T 3 -treated rats in vivo (23) .
Most investigations of glucose production in ZDF rats have focused on glycogen metabolism.
Among patients with poorly-controlled type 2 diabetes mellitus (T2DM), gluconeogenesis has a causative role in hepatic glucose over-production in the fasted state and glycogenolysis has been reported to be similar or less than control human subjects (10, (18) (19) . A male ZDF rat is an animal model of obesity and T2DM, yet studies of ZDF rats suggest that glycogenolysis may play an important role in hyperglycemia in the fasted state. Hepatocytes from fasted ZDF rats have higher rates of glycogen synthesis than hepatocytes from lean Zucker rats (20) , and glycogen stores are preserved to a greater extent in ZDF rats compared to lean animals during starvation (30) . Consequently, glycogenolysis may provide a source of glucose not available in lean animals after fasting.
These data suggest that metabolic fluxes associated with glucose production of T2DM and hyperthyroidism may differ substantially. However, only a subset of relevant pathways was examined in each study, and the requirement of most methods for liver tissue restricts use of these methods in humans.and 2 H NMR offer a flexible, comprehensive and essentially non-invasive approach to analysis of metabolic fluxes in vivo. One important advance was the ability to monitor glycogen stores in vivo by 13 C NMR which provides a direct measure of glycogenolysis (10, 18, 25) . Other methods to characterize glucose production require only analysis of blood samples (15) . Jin et al. recently introduced the use of 13 C NMR coupled with [3, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose to measure glucose turnover (14) . This approach is convenient because the characteristic 13 C -13 C spin-spin coupling in tracer carbons 3 and 4 is easily distinguished from 13 C enrichment in carbon positions 1, 2, 5 or 6 that arises from 13 C label entering the TCA cycle from labeled gluconeogenic precursors. Further, the presence of low levels of 13 C enrichment in plasma glucose does not interfere with analysis of deuterium exchange in the same experiment using 2 H NMR.
Thus, this triple tracer method allows multiple aspects of systemic glucose production to be probed in a single experiment.
The objective of this study was to measure fluxes in relevant pathways using only 13 C and 2 H NMR of plasma glucose in two previously studied rat models of excess glucose production. We tested the hypothesis that the distribution of 13 C and 2 H in plasma glucose would be sensitive to these two disease states and that the sources of excess glucose production in these two models would differ.
Although glucose production was identical in both ZDF and T 3 -treated rats and significantly elevated compared to normal controls, the metabolic networks supporting glucose production in T 3 -treated and ZDF animals differed substantially. Since these measurements may be obtained from a single sample of plasma glucose, extension of the technique to humans is straightforward. Glucose overproduction in hyperthyroid and ZDF rats page 5 Supelco (St. Louis, MO). Protein assay reagents were purchased from Bio-Rad (Hercules, CA). Other common chemicals were purchased from Sigma (St. Louis, MO).
MATERIALS AND METHODS

Materials
Protocol
The study was approved by the Institutional Animal Care and Use Committee at the University of Texas Southwestern Medical Center. Three different groups of rats were studied: male Sprague-Dawley rats (220 ± 31g), T 3 -treated male Sprague-Dawley rats (236 ± 16 g after T 3 treatment) and 19-20 week old male ZDF rats (482 ± 68 g). T 3 -treated rats were given T 3 in their drinking water for 5 days before initiation of the experiment. One liter of drinking water was prepared by dissolving 2 mg of T 3 into 200 µL of NaOH (50 mM) followed by dilution to 1 L. This solution was added to each liter of drinking water. T 3 -treated rats lost 20.7 ± 8.4 g during 5 days of T 3 treatment including the 24 hr fasting period.
All rats were fasted for 24 hr with free access to water after which the jugular vein was cannulated under ketamine-xylazine anesthesia. Rats received an intraperitoneal injection (20 µL/g rat) containing [U- 13 (4.0 mg/mL water) at a rate of 1.0 mL/hr for 90 min. At the conclusion of the 90 min infusion period, blood was drawn from the descending aorta and the liver was freeze-clamped and stored at the -80°C until processed.
Sample Processing for NMR Analysis
Blood was immediately centrifuged and plasma supernatant was deproteinized by adding cold perchloric acid to a final concentration of 7% by volume. After neutralization with KOH and centrifugation, the supernatant was lyophilized. To convert plasma glucose into monoacetone glucose (MAG, Figure 1 ), the dried residue was suspended in 3.0 mL of acetone containing 120 µL of concentrated sulfuric acid. The mixture was stirred for 4 hr at room temperature to yield diacetone
Glucose overproduction in hyperthyroid and ZDF rats page 6 glucose. After filtering off particulates and adding 3 mL of water, the pH was adjusted to 2.0 by dropwise addition of 1.5M Na 2 CO 3 . The mixture was stirred for 24 hr at room temperature to convert diacetone glucose into MAG. The pH was then further increased to ~8.0 by dropwise addition of Na 2 CO 3 . Acetone was evaporated under a vacuum and the sample was freeze-dried. MAG was extracted into 3 mL (5x) of hot ethyl acetate, the solutions were combined and the ethyl acetate was removed by vacuum evaporation.
The resulting MAG was further purified by passage through a 3 mL DSC-18 cartridge using 5% acetonitrile as eluant. The effluent was freeze-dried and stored dry prior to NMR analysis.
A 5-10 g portion of liver tissue was used for glycogen extraction and purification (21) . Isolated liver glycogen was dissolved in 5 mL of 10 mM sodium acetate solution (pH 4.8) and incubated with amyloglucosidase (50 mg glycogen/20 units of amyloglucosidase) for 4 hr at 50 °C. After freeze-drying, the glucose was converted to MAG as described above.
NMR Spectroscopy
MAG was dissolved in 90% acetonitrile-10% water.
2 H NMR spectra were collected using a 13 C NMR spectra were collected using the same spectrometer and probe with the observe coil tuned to 13 C (150 MHz). Prior to 13 C spectroscopy, the MAG samples were dried and resuspended in deuterated acetonitrile. Proton-decoupled 13 C NMR spectra were acquired at 25°C using a 52° observe pulse, 1.5-s acquisition time and no delay between pulses. Typically
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Glucose Turnover and Metabolic Fluxes
Glucose turnover was estimated from the dilution of infused [3, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose using 13 C NMR to analyze MAG derived from plasma glucose at the end of the infusion protocol (14) . Briefly, the fraction of [3,4-13 C 2 ]glucose in plasma glucose was determined from the ratio of the areas of the doublet due to J 3, 4 in carbon 3 (at 75.3 ppm) and in carbon 4 (at 80.5 ppm) compared to the total area of the two methyl resonances (at 26.1 and 26.7 ppm). Since the methyl resonances reflect natural abundance 13 C, the fraction of [3, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose in MAG was evaluated based upon standard curves (14) . Glucose production was calculated from the known infusion rate (R i ), the fraction of infusate glucose that was
, and the fraction of plasma glucose that was [3, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose (L p ) at the end of the infusion period:
Flux from glycogen, glycerol, and PEP into plasma glucose was estimated from the deuterium enrichment at positions 2, 5 and 6 S as determined from the 2 H NMR of MAG. 
A 13 C NMR isotopomer analysis based on the 13 C-13 C spin-coupled multiplets of C2 of MAG has been reported previously which yields relative fluxes in the citric acid cycle as follows:
where the variables C2Q, C2D12, and C2D23 are the areas of the quartet, doublet due to J 12 , doublet due to J 23 , relative to the area of the C2 resonance. The assumptions in the metabolic model include 1) all glucose originates from the liver, 2) hydrolytic conversion of glycogen to glucose via amylo- Each variable used to describe the metabolic results (v1 -v7) generally describes the combined actions of multiple enzyme catalyzed reactions. For example, v2 indicates the rate of generation of glucose-6-phosphate from glycogen, without implying measurement of flux in a specific reaction.
Similarly, v5 is used to describe the flux of carbon skeletons from the PEP / pyruvate pool through carboxylation and regeneration of OAA. Flux from OAA to pyruvate to OAA can occur via the combined effects of either malate dehydrogenase, the malic enzyme and pyruvate carboxylase, or PEPCK, pyruvate kinase and pyruvate carboxylase. Hence, v5 simply designates the sum of fluxes through both pathways. Pyruvate carboxylase is common to both pathways, so v5 is also a lower limit on total flux through pyruvate carboxylase.
Metabolite Assays
Plasma glucose was assayed enzymatically (2). Freeze-clamped livers were pulverized under liquid nitrogen and a small portion (< 0.5 g) was extracted with perchloric acid (6%) and subsequently used for glycogen and lactate assays (2). The remaining portion of each pulverized liver (~5g) was suspended in 25 ml of 20 mM Tris-HCl (pH 7.4) buffer containing 0.25 M sucrose, 0.1mM dithiothreitol, and 0.1mM EDTA, homogenized and centrifuged at 800 × g for 10 min to remove cell debris. The supernatant was further centrifuged for at 8,500 × g for 15 min to separate a mitochondrial pellet. The pellet was washed (3×) with the buffer and the pellet was resuspended in 1.5-ml buffer. This represented the mitochondrial fraction while the supernatant represented the cytosolic fraction. Total protein in the mitochondrial and cytosolic fractions were measured using Bio-Rad assay reagents (3). The activities of ME and PK were determined on the cytosolic fraction (4, 11) . Malate in cytosolic fraction was measured enzymatically (2).
Statistical Analysis
The data are expressed as mean ± standard deviation. Comparisons between groups were performed using one-way analysis of variance. A p value < 0.05 was considered significant.
RESULTS
Glucose Production by Dilution of [3,4-13 C 2 ]glucose
Plasma glucose was higher in ZDF rats after a 24 hr fast than in T 3 -treated rats and controls (Table 1) . Typical 13 C NMR spectra of MAG from a T 3 -treated rat, a ZDF rat and a control rat are shown in Figure 1 Glucose overproduction in hyperthyroid and ZDF rats page 10 and ZDF rats, respectively. Given the known infusion rates of [3, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose, this corresponds to glucose production rates of 40.4, 94.5 and 86.5 µmol/kg/min, respectively (Table 2 ). This indicates that hepatic glucose production was ~2-fold higher both in T 3 -treated rats and in ZDF rats compared to controls.
Glycogen Stores and Sources of Plasma Glucose by 2 H NMR
Liver glycogen was essentially depleted in control animals and in T 3 -treated rats after a 24 hr fast but remained high (112.7 ± 9.3 µmol glucosyl unit/gww, Table 1 ) in ZDF rats after a similar period of fasting. This was also reflected in the contribution of hepatic glycogen to plasma glucose as determined The difference between H5 and H6s was modest for all three groups with the fractional contribution of glycerol to glucose ranging from 13 to 17% (Table 2 ). The H6s/H2 ratio, an index of the contribution of PEP to glucose production, was ~80% in controls and T 3 -treated rats, but significantly lower, 40%, in ZDF rats (Table 2 ).
The absolute rates of glucose formation from glycogen, PEP, and glycerol were determined by multiplying the individual fractional contributions times the glucose production rates. These values are summarized in Table 2 . Glycogenolysis was ~41 µmol/kg/min in ZDF rats but negligible in controls and T 3 -treated rats. Gluconeogenesis from glycerol was significantly higher in both T 3 -treated rats (p < 0.05) and ZDF rats (p < 0.01) compared to controls while gluconeogenesis from PEP was ~2-fold higher in T 3 -treated rats than controls and ZDF rats.
C Labeling in Plasma Glucose
Jin et al.
Glucose overproduction in hyperthyroid and ZDF rats page 11
Entry of [U- 13 C 3 ] propionate into the TCA cycle via propionyl-CoA, methylmalonyl-CoA and succinyl-CoA and subsequent turnover produces a mixture of 13 C isotopomers in all intermediates and in molecules in exchange with those intermediates. Since glucose is derived from OAA, one would anticipate that MAG derived from plasma glucose would show extensive couplings in its 13 C NMR spectrum ( Figure 3 ). To confirm that plasma glucose had achieved isotopic steady-state enrichment from
[U- 13 C 3 ] propionate, an additional experiment was performed using 24-hr fasted Sprague-Dawley rats (n = 3, 251 ± 15 g). The same amount of [U-13 C 3 ]propionate/ 2 H 2 O was injected intraperitoneally and blood was drawn from the descending aorta at different time points (60 min, 120 min and 150 min). Plasma glucose at each time point was converted into MAG and scanned by 13 C NMR. As illustrated in the top graph of Figure 3 , the C2 multiplet ratios, Q/D23 and D12/D23, seen in the spectra of MAG were relatively constant and similar to the values measured in spectra of MAG derived from control animals at 90 min. Over the entire study period (60 to 150 min), the D12/D23 and Q/D23 ratios varied no more than 5.3-5.6 and 2.5-2.7, respectively (Figure 3a) . Conversely, the absolute 13 C enrichment of carbon 2 of plasma glucose as estimated from 1 H NMR spectra of MAG (15) was 3.5 ± 0.1% at 60 min, 4.4 ± 0.3% at 90 min, 3.1 ± 0.4% at 120 min, and 2.3 ± 0.4% at 150 min. This indicates that while the total contribution of [U- 13 C 3 ] propionate to plasma glucose reaches a maximum at 90 min, the multiplet ratios which were used to derived the metabolic fluxes reported here were indeed constant over this study period. Figure 3 shows that the multiplet pattern of the MAG C2 resonance from a T 3 -treated rat differed from that of a control and a ZDF rat. In particular, the doublet due to J 23 is larger than that of quartet in MAG from a T 3 -treated rat compared to control and ZDF animals. An analysis of the C2 multiplets using equations 5-7 provides a measure of flux through PEPCK, pyruvate cycling and gluconeogenesis all relative to citrate synthase flux. These data indicate that all three flux ratios (v4/v7, v5/v7, v6/v7) were significantly smaller in T 3 -treated rats compared to ZDF or control rats (Table 2) . However, upon converting these flux ratios into absolute flux values via the metabolic network shown in Figure 4 , a somewhat different picture emerges. Specifically, absolute flux from PEP glucose (v4) was ~2-fold greater, PEPCK flux (v6) and pyruvate cycling (v5) fluxes were ~4-fold greater, and TCA cycle flux (v7)
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was ~5-fold greater in T 3 -treated animals than either ZDF rats or controls while these same absolute fluxes did not vary significantly between ZDF and control rats. It was also interesting that the total mitochondrial protein content and the mitochondrial pellet volume in livers of T 3 -treated rats was ~2-fold higher than in either ZDF or control rats (Table 1) consistent with an increased TCA cycle capacity in these animals.
H NMR Analysis of Liver Glycogen in Conscious ZDF Rats
The fact that glycogen stores in ZDF rats were preserved after a 24-hr fast (Table 1) Liver glycogen cycling was also substantial as confirmed by low H5/H2 ratio in Figure 5 .
DISCUSSION
This study demonstrates that patterns of glucose production may be distinguished by a simple NMR analysis of tracers in plasma glucose. The general features of abnormal glucose metabolism established in prior invasive studies were confirmed using only plasma samples, including the preserved capacity for glycogen release in ZDF animals and increased flux in the pyruvate cycling in T 3 -treated animals. To our knowledge, this is the first report detecting abnormal pyruvate cycling in the liver using only
Jin et al.
Glucose overproduction in hyperthyroid and ZDF rats page 13 plasma samples, and it is the first demonstration that preserved glycogen stores in ZDF animals are associated with excess glucose production from glycogen. The study also illustrates the advantages of judi- 
Role of Glycogen in Excess Glucose Turnover in ZDF Rats
The role of hepatic glucose production in the hyperglycemia of T2DM is controversial. Recent studies suggested that excess hepatic gluconeogenesis plays a causative role in hyperglycemia (10, (18) (19) ). While the current study involves only an animal model of T2DM, it illustrates the value of simultaneous measurement of all sources of glucose. In fed ZDF rats, glycerol was reported to be a major substrate for hepatic glucose production (29) . While statistically significant increases in gluconeogenesis from glycerol were confirmed in ZDF animals in this study, these changes were modest in the context of total glucose production and the overall impact of this change was small (Figure 4 ).
The main observations were that the glycogen content was higher in ZDF animals after a 24-hr fast compared to controls which correlated with the noninvasive 2 H NMR analysis, and that increased glycogenolysis rather than excess gluconeogenesis was the source of increased glucose production under these conditions. Earlier reports demonstrated that the glycogen content is higher in obese ZDF animals and, paradoxically, that glycogen stores are higher after a 6-day fast compared to a 2-4-day fast (30) .
Earlier reports also indicated that hepatocytes from obese ZDF rats had a higher rate of glycogen synthesis compared to hepatocytes from lean ZDF rats (20) . However, others have reported impaired glycogen synthesis in ZDF animals (1, 31) . The mechanism of preserved glycogen stores in these
Glucose overproduction in hyperthyroid and ZDF rats page 14 animals could be the result of reduced glycogenolysis, increased glycogen synthesis, or combination of both. The observation that the H2 of glycogen glucosyl units are enriched with 2 H suggests continued glycogen synthesis in fasted animals, yet a role for reduced glycogenolysis cannot be excluded. Since the hyperglycemia of ZDF rats may be an important inhibitor of glycogenolysis (24), the mechanism of preserved glycogen stores in these animals is unclear. However, there is no doubt (see the 2 H NMR spectra in Figure 2 ) that the preserved glycogen stores can be mobilized, at least during the conditions used in the present experiments.
The activity of two key enzymes that may be involved with pyruvate cycling, PK and ME, were increased significantly in ZDF animals (Table 1) , as was the concentration of malate, the substrate for the ME. Together these measurements might be interpreted as strong evidence for increased pyruvate cycling which would fit nicely with a possible requirement for increased NADPH to support lipogenesis in ZDF rats. In spite of these indirect measurements suggesting an increase in flux through pyruvate cycling, the absolute pyruvate cycling flux as measured by NMR in ZDF animals (160 ± 52 µmol/kg/min) was virtually identical to that measured for controls (154 ± 43 µmol/kg/min).
Excess Gluconeogenesis via the TCA Cycle in T 3 -Treated Rats
This study used a different approach to measure pyruvate cycling compared to prior studies in Hyperthyroidism causes increased hepatic glucose production and a dramatic alteration of hepatic mitochondrial function, including increased oxygen consumption, protein content, and longer and more numerous cristae (12, 27, 32) . These prior observations are entirely consistent with an enhanced TCA cycle flux as found here for T 3 -treated rats. One might anticipate that such a dramatic increase in TCA cycle flux as found here for T 3 -treated rats might lead to proportional excess glucose production in these animals. However, pyruvate cycling flux was also dramatically higher in T 3 -treated animals and this levels much of the excess cataplerotic flux from the cycle (v6) by redirecting a larger percentage of those carbons back into the TCA cycle. The net effect is that gluconeogenesis from PEP is only 120% higher in T 3 -treated rats compared to ZDF or control animals even though TCA cycle flux (v7) and total cataplerotic outflow (v6) are 380% and 250% higher, respectively, in T 3 -treated rats compared to ZDF or control animals. These results suggest that pyruvate cycling may play a functional role in protecting against overproduction of glucose production in liver by modulating gluconeogenesis from the TCA cycle during alterations in mitochondrial activity.
This study compared metabolic fluxes in controls, T 3 -treated rats and ZDF rats after a 24-hr fast and during ketamine-xylazine anesthesia. Both T 3 -treated rats and ZDF rats showed enhanced gluconeogenesis from glycerol compared to control animals. The distinguishing feature of T 3 -treated rats was enhanced gluconeogenesis from the TCA cycle and excess pyruvate cycling compared to both ZDF and controls. For ZDF rats, the characteristic metabolic pattern was excess glycogenolysis, possibly stimulated by surgical stress or anesthesia (9) . The important observation was that the distribution of 2 H in plasma glucose correctly reported the preserved glycogen stores. Based on the 2 H labeling in glucosyl units of glycogen ( Figure 5 ), it appears that glycogen synthesis continues in livers of ZDF rats even during fasting.
It is also interesting that despite increased ME and PK activities and higher steady state levels of malate in ZDF rats, the measured pyruvate cycling flux (v5) did not differ from control animals.
However, this observation should be interpreted with caution because it is based on fluxes normalized to body mass. ZDF rats would have higher fluxes than the values in Table 2 if the values were reported per rat. For example, the pyruvate cycling would be ~36 µmol/rat/min (154 µmol /kg/min × 0.236 kg) for controls and ~77 µmol/rat/min (159.9 µmol /kg/min × 0.482 kg) for ZDF rats without normalization to body mass. With that perspective, the measured activities of ME and PK are fully consistent with measured pyruvate cycling fluxes in controls and ZDF rats. If we expand the unit into gluconeogenesis, again ZDF rats would have higher gluconeogenesis than controls. Conversely, cytosolic malate levels were no different in controls versus T 3 -treated animals and ME and PK activities differed only slightly, yet pyruvate cycling flux was ~4-fold higher in T 3 -treated animals compared to controls. These observations underscore the importance of combining flux measurements with assays of enzyme activity or metabolite levels for highlighting metabolic phenotype differences.
Previously we reported that a primed 90-min infusion was sufficiently long to accurately measure glucose turnover in rats by comparing the 90 min results with those after a primed 150-min infusion (14) .
Ideally steady-state should be confirmed in turnover measurements by serial blood samples in each rat over the infusion time course, but this was not practical in the current study due to the inherently low sensitivity of NMR, especially 2 H NMR. Previous NMR studies from other labs have also indicated that steady state was achieved after primed 60-min infusion in rats (28). An earlier report found that steady state in plasma glucose specific radioactivity during infusion of [ 3 H]glucose was achieved very quickly and was maintained throughout a 15 min to 120 min infusion period in ZDF rats (29) . Based on these previous observations, a 90-min infusion period was considered sufficient to reach steady state in the present experiments for both control and ZDF rats.
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The constant ratios of D12/D23 and Q/D23 of C2 resonances from rats at different time points (Figure 3 ) also indicates that isotopic steady state enrichment of plasma glucose from [U- 13 C 3 ] propionate was achieved at 90 min. Since [U- 13 C 3 ] propionate was administered as a bolus, the absolute 13 C enrichment was not constant throughout the study period. However, it is important to underscore the fact that analysis of glucose C2 (or MAG C2) depends only on the multiplet patterns detected in the 13 C NMR spectrum, not on the absolute 13 C enrichment.
Glucose production was assumed to originate from the liver in these experiments even though one cannot exclude production from other organs such as kidney. The role of the kidney in glucose production during disease states is essentially unknown. Approximately 20% of glucose production is considered to come from kidney in postabsorptive state of normal humans (6, 8) . If gluconeogenesis from the kidney (or small intestine) is significant in the current studies, the estimates of systemic production of glucose from glycogen, gluconeogenesis from glycerol and gluconeogenesis from the TCA cycle would remain unaltered. However, gluconeogenesis reported here as occurring in the liver would be decreased in proportion to the flux through gluconeogenesis occurring elsewhere. The model used to interpret the spectra, of course, is independent of the observation that 2 H and 13 C distribution in plasma glucose was altered in these models of disease.
In summary, two animal models of excess systemic glucose turnover were chosen based on earlier reports that suggested glucose production may be increased via different mechanisms. The metabolic patterns observed in these animals using only stable tracer distribution in plasma glucose corresponded well with those reported by more invasive methods. Obvious clinical applications are suggested by these experiments. For example, T2DM is a heterogeneous disorder where the contributions of excess gluconeogenesis from the TCA cycle, gluconeogenesis from glycerol, versus glycogenolysis to glucose homeostasis remains controversial and the impact of drug therapy is poorly understood. In other disorders, for example fatty liver, measurement of hepatic TCA cycle flux is critical to understanding the balance between fat storage and fatty acid oxidation. This study increases confidence in this analysis using only plasma samples of glucose. Relative and absolute fluxes (µmol/min/kg) through key reactions in glucose production.
Glucose production was measured by detection of [3, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose by 13 C NMR.
Relative metabolic fluxes were determined by 2 H (H2, H5 and H6s) and 13 C NMR (C2 resonance) analysis of MAG derived from plasma glucose of controls (n=6), T 3 -treated rats (n=6), and ZDF rats (n=7). Abbreviations: CS, citrate synthase; PK, pyruvate kinase; ME, malic enzyme; PEP, phosphoenol pyruvate; PEPCK, phosphoenol pyruvate carboxykinase. Notations for fluxes, v1 -v7, are illustrated in Figure 4 . Figure 1 
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